Related Experiment Video

Updated: Aug 9, 2026

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
10:32

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Parkinsonism: a clinical marker of exposure to neurotoxins

M L Bleecker1

  • 1Johns Hopkins University School of Medicine, Department of Neurology, Francis Scott Key Medical Center, Baltimore, MD 21224.

Neurotoxicology and Teratology
|September 1, 1988
PubMed

Insights

Parkinsonism can result from damage to the nigrostriatal system caused by various neurotoxins. Different toxins like carbon monoxide, manganese, and MPTP lead to parkinsonism with varied neuropathology.

Area of Science:

  • Neuroscience
  • Toxicology

Background:

  • Parkinsonism is a clinical syndrome characterized by motor deficits.
  • The nigrostriatal system plays a crucial role in motor control.
  • Neuropathological lesions can disrupt nigrostriatal function, leading to parkinsonism.

Purpose of the Study:

  • To discuss the role of neurotoxic compounds in the development of parkinsonism.
  • To explore the varying neuropathology associated with different neurotoxin exposures.

Main Methods:

  • Review of literature on neurotoxin-induced parkinsonism.
  • Analysis of neuropathological findings in cases of toxic parkinsonism.

Main Results:

  • Exposure to neurotoxic compounds such as carbon monoxide, carbon disulfide, manganese, and MPTP is linked to parkinsonism.
  • The neuropathology observed in toxin-induced parkinsonism varies depending on the specific agent.
  • Parkinsonism can be considered a final common pathway for diverse neuropathological insults.

Conclusions:

  • Neurotoxic exposures represent a significant etiological factor in parkinsonism.
  • Understanding the specific neuropathology is key to differentiating toxin-induced parkinsonism from idiopathic Parkinson's disease.

More Related Videos

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease08:09

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease

Published on: January 7, 2014

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model05:38

Behavioral Assessments of Spontaneous Locomotion in a Murine MPTP-induced Parkinson's Disease Model

Published on: January 7, 2019

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...